Skip to main content
. 2015 Dec 10;2015(12):CD011984. doi: 10.1002/14651858.CD011984

Bahado‐Singh 2000a.

Clinical features and settings High‐risk referral for invasive testing.
Participants 524 participants.
USA ‐ single hospital.
August 1995 ‐ April 1999.
Singleton pregnancies.
Pregnant women.
Mean age 36.6 years (SD 5.3 years) in those with Down’s detected and 37.0 years (SD 3.4 years) in those with euploid pregnancies.
14‐22 weeks' gestation.
Study design Prospective cohort study.
Target condition and reference standard(s) Down's syndrome: 24 cases.
Reference standard: amniocentesis.
Index and comparator tests Maternal age.
Second trimester serum hCG (IMX total β‐hCG kit, Abbott Laboratories), uE3 (DSL‐1400 Ultra‐sensitive unconjugated Estriol Radioimmunoassay kit) and AFP (IMX AFP kit, Abbott Laboratories).
Second trimester urinary beta core fragment (Spot specimens of urine ‐ 2‐step sandwich assay B120 monoclonal antibody).
Frozen samples tested for second trimester urinary hyperglycosylated hCG (Specific monoclonal antibody developed. 2‐step enzyme immunometric assay standardised for creatinine levels).
Follow‐up 100% karyotyping.
Aim of study To compare the concentration of hyperglycosylated human chorionic gonadotropin with serum triple screen for second trimester Down’s syndrome detection.
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Selective testing of high‐risk women as done in practice.
Acceptable reference standard? 
 All tests Yes Amniocentesis.
Partial verification avoided? 
 All tests Yes All women had a reference standard.
Differential verification avoided? 
 All tests Yes All women had the same reference standard.
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test.
Reference standard results blinded? 
 All tests Yes Reference standard interpreted without knowledge of index test results. 
Index test results blinded? 
 All tests Unclear Unclear if index test interpreted with knowledge of reference standard results.  
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice.
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements.
Withdrawals explained? 
 All tests No No details of withdrawals given.